MFBTD
STAB

MB Financial Bank - Trust Department’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

MB Financial Bank - Trust Department’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16
Closed – – 667
2015
Q1 		$0 Buy
+16
New +$66 ﹤0.01% 468

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Winfield Associates Cleveland, Ohio $276M AUM 15.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MB Financial Bank - Trust Department's STAB Position: Q2 2015 in Review

MB Financial Bank - Trust Department sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q2 2015, closing a stake of 16 shares.

MB Financial Bank - Trust Department first reported a position in STAB in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 18 funds tracked by Wall St. Rank hold STAB as of Q2 2015.

  • MB Financial Bank - Trust Department reported no remaining Statera Biopharma, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 16 Statera Biopharma, Inc. Common Stock shares in Q2 2015.
  • MB Financial Bank - Trust Department first reported a position in Statera Biopharma, Inc. Common Stock in Q1 2015 and held it in 1 quarter.
  • MB Financial Bank - Trust Department's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q1 2015.
  • 18 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q2 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q2 2015, filed 15 Jul 2015.